PDCD1 and hepatocellular carcinoma: The fecal samples of immune responders showed higher taxonomic richness and gene counts, enriched in Myxobacteria and Ruminococcaceae, which influenced the efficacy of anti-PD-1 immunotherapy and disease prognosis in HCC patients.